{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "the-guidelines", "type": "clause", "offset": [6, 20]}], "size": 25, "snippet": "means the guidelines of the ICH.", "samples": [{"hash": "cBr48DQZS4E", "uri": "/contracts/cBr48DQZS4E#ich-guidelines", "label": "License, Development and Commercialization Agreement (Windtree Therapeutics Inc /De/)", "score": 36.2854194641, "published": true}, {"hash": "eHddbL5PgxP", "uri": "/contracts/eHddbL5PgxP#ich-guidelines", "label": "License, Development and Commercialization Agreement (Windtree Therapeutics Inc /De/)", "score": 35.2888450623, "published": true}, {"hash": "h3zNRAGkSnG", "uri": "/contracts/h3zNRAGkSnG#ich-guidelines", "label": "Exclusive License Agreement (Brickell Biotech, Inc.)", "score": 33.0876121521, "published": true}], "hash": "524a4f3331c606efaede70a07771933f", "id": 1}, {"snippet_links": [{"key": "requirements-for-registration", "type": "clause", "offset": [64, 93]}, {"key": "human-use", "type": "definition", "offset": [117, 126]}], "size": 17, "snippet": "mean the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Harmonized Tripartite Guideline.", "samples": [{"hash": "dZZYKXYAuOi", "uri": "/contracts/dZZYKXYAuOi#ich-guidelines", "label": "License Agreement (Black Diamond Therapeutics, Inc.)", "score": 34.3593444824, "published": true}, {"hash": "4DMBPjjeJmf", "uri": "/contracts/4DMBPjjeJmf#ich-guidelines", "label": "License Agreement (HUTCHMED (China) LTD)", "score": 34.1581115723, "published": true}, {"hash": "cNeEjE30FXy", "uri": "/contracts/cNeEjE30FXy#ich-guidelines", "label": "License Agreement (BridgeBio Pharma, Inc.)", "score": 30.8507862091, "published": true}], "hash": "5f6d62bb1f46f3a1ee593dcd97b8ad37", "id": 2}, {"snippet_links": [{"key": "applicable-to", "type": "definition", "offset": [34, 47]}, {"key": "pharmaceutical-products", "type": "definition", "offset": [48, 71]}], "size": 12, "snippet": "means the then-current guidelines applicable to pharmaceutical products adopted by the International Conference on Harmonization.", "samples": [{"hash": "aspdC4LcIUX", "uri": "/contracts/aspdC4LcIUX#ich-guidelines", "label": "Development and License Agreement (Zogenix, Inc.)", "score": 22.6098556519, "published": true}, {"hash": "1SlnrqjJApq", "uri": "/contracts/1SlnrqjJApq#ich-guidelines", "label": "Development and License Agreement (Durect Corp)", "score": 21.8480491638, "published": true}, {"hash": "azD1FxFoKZA", "uri": "/contracts/azD1FxFoKZA#ich-guidelines", "label": "Development and License Agreement (Alpharma Inc)", "score": 21.0, "published": true}], "hash": "b1365c9da637edfbf56273c646cd05ed", "id": 3}, {"snippet_links": [{"key": "from-time-to-time", "type": "clause", "offset": [42, 59]}, {"key": "requirements-for-registration", "type": "clause", "offset": [122, 151]}, {"key": "human-use", "type": "definition", "offset": [175, 184]}], "size": 9, "snippet": "means all relevant guidelines promulgated from time to time by the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.", "samples": [{"hash": "fLADFdIPWKO", "uri": "/contracts/fLADFdIPWKO#ich-guidelines", "label": "Supply Agreement (Ligand Pharmaceuticals Inc)", "score": 22.1663246155, "published": true}, {"hash": "491apMidHED", "uri": "/contracts/491apMidHED#ich-guidelines", "label": "Captisol Supply Agreement (Ligand Pharmaceuticals Inc)", "score": 22.1663246155, "published": true}, {"hash": "kcBk8qU0j0O", "uri": "/contracts/kcBk8qU0j0O#ich-guidelines", "label": "Supply Agreement (Replidyne Inc)", "score": 21.0, "published": true}], "hash": "ff5cd0fb0452a4d9f12b22239f6d3b51", "id": 4}, {"snippet_links": [{"key": "international-council", "type": "definition", "offset": [24, 45]}, {"key": "requirements-for", "type": "clause", "offset": [77, 93]}, {"key": "human-use", "type": "definition", "offset": [114, 123]}], "size": 8, "snippet": "means guidelines set by International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.", "samples": [{"hash": "8bFvlaEA6bk", "uri": "/contracts/8bFvlaEA6bk#ich-guidelines", "label": "Collaboration and License Agreement (Xencor Inc)", "score": 35.1601638794, "published": true}, {"hash": "l4XpingNeaf", "uri": "/contracts/l4XpingNeaf#ich-guidelines", "label": "Collaboration and License Agreement (Xencor Inc)", "score": 30.3497600555, "published": true}, {"hash": "l1kRyG9EJuP", "uri": "https://investors.xencor.com/static-files/de5735ef-d519-4ae6-b184-119fd15265ed", "label": "investors.xencor.com", "score": 7.9938397408, "published": false}], "hash": "9a935516536528e56000948876dc285e", "id": 5}, {"snippet_links": [{"key": "international-council", "type": "definition", "offset": [10, 31]}, {"key": "as-amended", "type": "definition", "offset": [62, 72]}, {"key": "from-time-to-time", "type": "clause", "offset": [73, 90]}], "size": 5, "snippet": "means the International Council for Harmonization guidelines, as amended from time to time.", "samples": [{"hash": "6ckIv9GCUYs", "uri": "/contracts/6ckIv9GCUYs#ich-guidelines", "label": "License and Commercialization Agreement (Harmony Biosciences Holdings, Inc.)", "score": 33.8323059082, "published": true}, {"hash": "6b5FLpNfvhh", "uri": "/contracts/6b5FLpNfvhh#ich-guidelines", "label": "License and Commercialization Agreement (Harmony Biosciences Holdings, Inc.)", "score": 31.5954818726, "published": true}, {"hash": "9QdLWrhcS2h", "uri": "/contracts/9QdLWrhcS2h#ich-guidelines", "label": "License and Commercialization Agreement (Harmony Biosciences Holdings, Inc.)", "score": 31.5681037903, "published": true}], "hash": "1d5cc2b40bb90a344759b10493d521fd", "id": 6}, {"snippet_links": [{"key": "practice-guide", "type": "definition", "offset": [50, 64]}, {"key": "active-pharmaceutical-ingredients", "type": "clause", "offset": [69, 102]}, {"key": "requirements-for", "type": "clause", "offset": [175, 191]}], "size": 5, "snippet": "means the document titled \u201cQ7A\u2014Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients\u201d endorsed by the International Conference on Harmonisation of Technical Requirements for Registrations of Pharmaceuticals.", "samples": [{"hash": "kAGfL2t2f3I", "uri": "/contracts/kAGfL2t2f3I#ich-guidelines", "label": "Supply Agreement", "score": 31.3408622742, "published": true}, {"hash": "exQEc9nmoAH", "uri": "/contracts/exQEc9nmoAH#ich-guidelines", "label": "Supply Agreement (Dance Biopharm, Inc.)", "score": 25.1724853516, "published": true}], "hash": "ec6894946324713569d054c052b27a42", "id": 7}, {"snippet_links": [], "size": 5, "snippet": "has the meaning set forth in Section 1.67 (GCP).", "samples": [{"hash": "7jUON6fj1x0", "uri": "/contracts/7jUON6fj1x0#ich-guidelines", "label": "Exclusive License Agreement (Innate Pharma SA)", "score": 35.2559890747, "published": true}, {"hash": "eDrwJ0QFUTe", "uri": "/contracts/eDrwJ0QFUTe#ich-guidelines", "label": "Exclusive License Agreement (Neurocrine Biosciences Inc)", "score": 31.5872688293, "published": true}], "hash": "a0621d8f7d0d5d3a1eb927c8e9fc0573", "id": 8}, {"snippet_links": [], "size": 4, "snippet": "has the meaning set forth in Section 1.25.", "samples": [{"hash": "bLgPZtA1Tdd", "uri": "/contracts/bLgPZtA1Tdd#ich-guidelines", "label": "Exclusive Option Agreement (Ascentage Pharma Group International)", "score": 35.986995697, "published": true}, {"hash": "1ybBwaTECDr", "uri": "/contracts/1ybBwaTECDr#ich-guidelines", "label": "Exclusive Option Agreement (Ascentage Pharma Group International)", "score": 35.5790557861, "published": true}], "hash": "88f27b48967012b14ef58b06d33325ab", "id": 9}, {"snippet_links": [{"key": "good-clinical-practice", "type": "clause", "offset": [88, 110]}], "size": 3, "snippet": "means the International Conference on Harmonization Harmonized Tripartite Guideline for Good Clinical Practice.", "samples": [{"hash": "crsIRb4R1hm", "uri": "/contracts/crsIRb4R1hm#ich-guidelines", "label": "Medical Imaging Services Agreement", "score": 34.2469558716, "published": true}, {"hash": "ioeGQuqs8tY", "uri": "/contracts/ioeGQuqs8tY#ich-guidelines", "label": "Medical Imaging Services Agreement", "score": 34.1088256836, "published": true}], "hash": "0ad79c59f99d552ac5098f7b0aa847cb", "id": 10}], "next_curs": "ClsSVWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjcLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIXaWNoLWd1aWRlbGluZXMjMDAwMDAwMGEMogECZW4YACAA", "definition": {"title": "ICH Guidelines", "size": 119, "snippet": "means the guidelines of the ICH.", "id": "ich-guidelines", "examples": ["The medical records or other Source Documents, as defined by <strong>ICH Guidelines</strong>, that support the Study Results shall remain the property of Institution.", "The medical records or other Source Documents, as defined by current <strong>ICH Guidelines</strong>, that support the Study Results shall remain the property of Institution.", "IntelGenx shall provide Par with copies of any Form FDA 483 or other correspondence from the FDA or other applicable Governmental Authority regarding the compliance with Applicable Laws, including cGMP and <strong>ICH Guidelines</strong>, within one (1) business day of receipt by IntelGenx of such correspondence.", "Application, shall comply in all material respect with <strong>ICH Guidelines</strong> (or other comparable regulation and guidance of any Regulatory Authority in the Territory), and, if and as applicable, the regulations and guidance of the FDA that constitute GLP and GMP.", "Rhythm shall be responsible for reporting all adverse events (as defined in the then current edition of <strong>ICH Guidelines</strong> and any other relevant regulations or regulatory guidelines or any other safety problem of any significance, hereafter \u201cAdverse Events\u201d) relating to the Product to the appropriate regulatory authorities in the countries in the Territory in accordance with the appropriate laws and regulations of the relevant countries and authorities.", "Dermira shall diligently, in good scientific manner and in accordance with prevailing industry practices concerning the conduct of Clinical Studies, GCP, <strong>ICH Guidelines</strong> and Applicable Law, attempt to identify, or cause to be identified, and to resolve expeditiously, inconsistencies and deficiencies in Product Data from any Phase 3 Study, or any Post-Approval Study in the Development Indication, conducted by or on behalf of Dermira.", "I agree to conduct the study as detailed herein and in compliance with <strong>ICH Guidelines</strong> for Good Clinical Practice and applicable regulatory requirements and to inform all who assist me in the conduct of this study of their responsibilities and obligations.", "All pre-clinical and clinical work, studies, and trials conducted, supervised, or monitored by PTI with respect to any Designated Product and that are intended to be used to support Regulatory Approval, have, to the Knowledge of PTI, been conducted and performed in substantial compliance with Applicable Laws, including Good Laboratory Practice, Good Clinical Practice, and Good Manufacturing Practice requirements and <strong>ICH Guidelines</strong>.", "As soon as possible, but in all cases within [***] ([***]) months after Data Lock for the applicable Clinical Trial, Prothena shall provide to Celgene (or a Third Party advisor designated by Celgene) the final study report for the Phase 1 Clinical Trial for such Program (which shall be prepared in accordance with customary practice that meets the standards of ICH Topic E3 of <strong>ICH Guidelines</strong> for Structure and Content of Clinical Study Reports dated July 1996).", "Furthermore, such agreed procedure will be consistent with relevant <strong>ICH Guidelines</strong>, except where said guidelines may conflict with existing local regulatory or safety reporting requirements, in which case local reporting requirements shall prevail."], "related": [["fitch-guidelines", "Fitch Guidelines", "Fitch Guidelines"], ["2-25-guidelines", "2%/25% Guidelines", "2%/25% Guidelines"], ["guidelines", "Guidelines", "Guidelines"], ["program-guidelines", "Program Guidelines", "Program Guidelines"], ["ecb-str-guideline", "ECB \u20acSTR Guideline", "ECB \u20acSTR Guideline"]], "related_snippets": [], "updated": "2026-03-14T06:33:37+00:00"}, "json": true, "cursor": ""}}